Federated Hermes, Inc. Akouos, Inc. Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $1.58 Million - $3.13 Million	607,297 Added 17.96%	3,988,967 $27 Million
Q2 2022 Aug 15, 2022	BUY	$2.46 - $5.2 $1.83 Million - $3.86 Million	743,208 Added 28.17%	3,381,670 $15.9 Million
Q1 2022 May 13, 2022	BUY	$4.16 - $9.08 $582,483 - $1.27 Million	140,020 Added 5.6%	2,638,462 $12.5 Million
Q4 2021 Feb 14, 2022	SELL	$7.65 - $11.38 $553,385 - $823,206	-72,338 Reduced 2.81%	2,498,442 $21.2 Million
Q2 2021 Aug 16, 2021	BUY	$11.87 - $15.96 $725,233 - $975,124	61,098 Added 2.43%	2,570,780 $32.3 Million

Q1 2021 May 13, 2021	BUY	$13.87 - $21.04 $2.64 Million - $4 Million	190,200 Added 8.2%	2,509,682 $34.8 Million
Q4 2020 Feb 12, 2021	BUY	$17.03 - $22.45 $2.97 Million - $3.91 Million	174,279 Added 8.12%	2,319,482 $46 Million
Q3 2020 Nov 12, 2020	BUY	$19.3 - $26.92 $29.9 Million - $41.6 Million	1,546,990 Added 258.6%	2,145,203 $49.1 Million
Q2 2020 Aug 13, 2020	BUY	$22.0 - $22.5 $13.2 Million - $13.5 Million	598,213 New	598,213 $13.5 Million

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.